Rabeprazole D4
| Product Name | Rabeprazole D4 |
|---|---|
| Alternate Names | Rabeprazole Stable Isotopes, Stable Isotopes of Rabeprazole |
| CAT No. | CS-T-60935 |
| CAS No. | 934295-48-4 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 363.47 g/mol |
| Mol. For. | C₁₈H₁₇D₄N₃O₃S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Rabeprazole |
| Purity | 95% |
| Therapeutic | Anti ulcer |
| Smileys | O=[S](C(NC1=C(C([2H])=C2[2H])[2H])=NC1=C2[2H])CC(N=CC=C3OCCCOC)=C3C |
| Canonical Smiles | CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC |
| InchIKey | YREYEVIYCVEVJK-ZDPIWEEJSA-N |
| Inchl | InChI=1S/C18H21N3O3S/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)/i3D,4D,6D,7D |
| IUPAC | 4,5,6,7-tetradeuterio-2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Rabeprazole D4 is a deuterated form of Rabeprazole, which is a proton pump inhibitor (PPI) that is commonly used for the treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD), and Zollinger-Ellison syndrome. Rabeprazole D4 is typically used in pharmacokinetic and bioavailability studies to track the metabolism and elimination of Rabeprazole in the body.
Chemically, Rabeprazole D4 is a substituted benzimidazole derivative that works by irreversibly binding to the H+/K+-ATPase enzyme in the parietal cells of the stomach, which reduces the secretion of acid into the stomach. This results in a decrease in the amount of acid that comes in contact with the esophagus, which can alleviate symptoms such as heartburn and acid reflux.
The recommended dosage of Rabeprazole D4 varies depending on the condition being treated and the patient's individual needs. It is typically administered orally in the form of a tablet, capsule, or suspension.
Like any medication, Rabeprazole D4 may cause side effects, such as headache, nausea, diarrhea, and abdominal pain. It may also interact with other medications, such as warfarin and ketoconazole.
Overall, Rabeprazole D4 is an important tool for researchers and healthcare professionals in understanding the pharmacokinetics and bioavailability of Rabeprazole, which helps to optimize its use in the treatment of various gastrointestinal conditions.
Get an Instant Quote
Related Compounds
Rabeprazole D4 sodium salt | Rabeprazole Sulfone-d3 | S-Rabeprazole D3 | Rabeprazole-13CD3 | R- Rabeprazole D3 | Rabeprazole-d3 Sulfide | Rabeprazole 13C D3 Sodium salt | Rabeprazole-D4 potassium | Rabeprazole-d3 Sodium Salt |